重庆市18家医院2004~2006年调脂药应用分析

目的:了解重庆市调脂药的应用现状及趋势,为该类药的研发、生产、销售和临床应用提供参考。方法:对重庆市18家医院2004~2006年调脂药的销售金额、用药频度(DDDs)、日均费用(DDC)等进行统计、分析。结果:调脂药的销售金额和DDDs呈逐年上升趋势。其中,他汀类药的销售金额分别占总销售金额的48.37%、47.74%、61.79%,始终列第1位;其次是中成药类和苯氧芳酸类。DDDs排序列前2位的药品是血脂康和辛伐他汀。结论:他汀类和中成药占重庆市调脂药市场的主导地位,其前景看好。

Use of Antihyperlipidemics in 18 Hospitals of Chongqing from 2004 to 2006

OBJECTIVE: To analyze the status quo and developing trend of the use of antihyperlipidemics drugs in Chongqing so as to provide information for the research,production,marketing and clinical application of these drugs.METHODS: The consumption sum,DDDs and the defined daily cost(DDC) of Antihyperlipidemics in 18 hospitals in Chongqing city from 2004 to 2006 were analyzed statistically.RESULTS: Both the DDDs and the consumption sum of the antihyperlipidemics showed uptrend over the 3 years,with statins dominating the first place over the 3 consecutive years,making up 48.37%,47.74%,and 61.79% respectively,followed by Chinese patent medicines and fibrates.Xuezhikang and simvastatin ranked among the first two places in terms of DDDs.CONCLUSION: Statins and Chinese patent medicines occupied a predominant role among all the antihyperlipidemic drugs in Chongqing,and their use had a bright prospect.